These tentative findings suggest the potential of the miR‐32533/CREB5/Aβ signaling axis as a novel therapeutic target for mitigating Aβ toxicity, oxidative stress, and neuroinflammation in AD, highlighting the significance of miRNA‐based therapeutic strategies. The gene discussed is CREB5; the disease is Alzheimer disease.